Cases 1 - 10 of 10
PATEL v. CAMBREX CORPORATION et al
as 2:2019cv18474
Defendant:
BERNHARD HAMPL, LOUIS J. GRABOWSKY, KATHRYN RUDIE HARRIGAN, PH.D. and others
Plaintiff:
BIREN PATEL
Thompson v. Cambrex Corporation et al
as 1:2019cv01793
Defendant:
Louis J. Grabowsky, Bernard Hampl, Ilan Kaufthal and others
Plaintiff:
John Thompson
STEIN v. CAMBREX CORPORATION et al
as 2:2019cv18106
Defendant:
BERNHARD HAMPL, LOUIS J. GRABOWSKY, KATHRYN RUDIE HARRIGAN, PH.D. and others
Plaintiff:
SHIVA STEIN
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7136
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellee:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellant:
Cambrex Corporation and Gyma Laboratories of America, Inc.
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7135
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellant:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellee:
Cambrex Corporation and Gyma Laboratories of America, Inc.
Celgro Corporation v. Cambrex Corporation
as 1:2009cv00639
Plaintiff:
Celgro Corporation
Defendant:
Cambrex Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
United States of America v. Napera, Inc. et al
as 1:2008cv05815
Plaintiff:
United States of America
Defendant:
Napera, Inc., Cambrex Corporation, Warner-Lambert Company, LLC and others
Cause Of Action: 42 U.S.C. § 9607 Real Property Tort to Land
In re: Lorazepam
as 08-5045
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Federal Trade Commission, State of Florida, By Attorney General Robert A. Butterworth, State of Illinois, By Attorney General James E. Ryan and others
Defendant - Appellee:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellant:
Gyma Laboratories of America, Inc. and Cambrex Corporation
In re: Lorazepam
as 08-5044
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Federal Trade Commission, State of Florida, By Attorney General Robert A. Butterworth, State of Illinois, By Attorney General James E. Ryan and others
Defendant - Appellant:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellee:
Gyma Laboratories of America, Inc. and Cambrex Corporation
In Re: LORAZEPAM/CLORAZE, et al v. MYLAN LABORATORIES, et al
as 1:1999mc00276
Plaintiff:
FEDERAL TRADE COMMISSION , STATE OF FLORIDA , STATE OF ILLINOIS and others
Defendant:
MYLAN LABORATORIES, INC. , CAMBREX CORPORATION , PROFARMACO S.R.L. and others
Movant:
AETNA US HEALTHCARE , CHAMBER OF COMMERCE OF THE UNITED STATES OF AMERICA , STEVEN ARONSON and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
